302 related articles for article (PubMed ID: 19153517)
1. Adrenocortical cancer treatment.
Patalano A; Brancato V; Mantero F
Horm Res; 2009 Jan; 71 Suppl 1():99-104. PubMed ID: 19153517
[TBL] [Abstract][Full Text] [Related]
2. Contemporary management of adrenocortical carcinoma.
Zini L; Porpiglia F; Fassnacht M
Eur Urol; 2011 Nov; 60(5):1055-65. PubMed ID: 21831516
[TBL] [Abstract][Full Text] [Related]
3. Adrenocortical carcinoma.
Rodgers SE; Evans DB; Lee JE; Perrier ND
Surg Oncol Clin N Am; 2006 Jul; 15(3):535-53. PubMed ID: 16882496
[TBL] [Abstract][Full Text] [Related]
4. Adrenocortical carcinoma.
van Ditzhuijsen CI; van de Weijer R; Haak HR
Neth J Med; 2007 Feb; 65(2):55-60. PubMed ID: 17379929
[TBL] [Abstract][Full Text] [Related]
5. [Adrenocortical carcinoma and its treatment].
Tupikowski W; Bednarek-Tupikowska G; Florczak A
Postepy Hig Med Dosw (Online); 2004 Feb; 58():27-36. PubMed ID: 15069374
[TBL] [Abstract][Full Text] [Related]
6. European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Dekkers OM; Else T; Baudin E; Berruti A; de Krijger R; Haak HR; Mihai R; Assie G; Terzolo M
Eur J Endocrinol; 2018 Oct; 179(4):G1-G46. PubMed ID: 30299884
[TBL] [Abstract][Full Text] [Related]
7. Clinical management of adrenocortical carcinoma.
Fassnacht M; Allolio B
Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):273-89. PubMed ID: 19500769
[TBL] [Abstract][Full Text] [Related]
8. Future directions in the diagnosis and medical treatment of adrenocortical carcinoma.
Creemers SG; Hofland LJ; Korpershoek E; Franssen GJ; van Kemenade FJ; de Herder WW; Feelders RA
Endocr Relat Cancer; 2016 Jan; 23(1):R43-69. PubMed ID: 26475053
[TBL] [Abstract][Full Text] [Related]
9. Mitotane associated with etoposide, doxorubicin, and cisplatin in the treatment of advanced adrenocortical carcinoma. Italian Group for the Study of Adrenal Cancer.
Berruti A; Terzolo M; Pia A; Angeli A; Dogliotti L
Cancer; 1998 Nov; 83(10):2194-200. PubMed ID: 9827725
[TBL] [Abstract][Full Text] [Related]
10. [Recent advances in the treatment of adrenocortical carcinomas].
Ducry J; Berthold D; Pralong F
Rev Med Suisse; 2012 Nov; 8(362):2181-4, 2186. PubMed ID: 23240320
[TBL] [Abstract][Full Text] [Related]
11. Mitotane associated with cisplatin, etoposide, and doxorubicin in advanced childhood adrenocortical carcinoma: mitotane monitoring and tumor regression.
Zancanella P; Pianovski MA; Oliveira BH; Ferman S; Piovezan GC; Lichtvan LL; Voss SZ; Stinghen ST; Callefe LG; Parise GA; Santana MH; Figueiredo BC
J Pediatr Hematol Oncol; 2006 Aug; 28(8):513-24. PubMed ID: 16912591
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma: clinical and laboratory observations.
Wajchenberg BL; Albergaria Pereira MA; Medonca BB; Latronico AC; Campos Carneiro P; Alves VA; Zerbini MC; Liberman B; Carlos Gomes G; Kirschner MA
Cancer; 2000 Feb; 88(4):711-36. PubMed ID: 10679640
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in adrenocortical carcinoma in adults.
Bourdeau I; MacKenzie-Feder J; Lacroix A
Curr Opin Endocrinol Diabetes Obes; 2013 Jun; 20(3):192-7. PubMed ID: 23549307
[TBL] [Abstract][Full Text] [Related]
14. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
15. Genomic and expression profiling of adrenocortical carcinoma: application to diagnosis, prognosis and treatment.
Bussey KJ; Demeure MJ
Future Oncol; 2009 Jun; 5(5):641-55. PubMed ID: 19519204
[TBL] [Abstract][Full Text] [Related]
16. Next-generation therapies for adrenocortical carcinoma.
Altieri B; Ronchi CL; Kroiss M; Fassnacht M
Best Pract Res Clin Endocrinol Metab; 2020 May; 34(3):101434. PubMed ID: 32622829
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis, treatment and outcome of adrenocortical cancer.
Mihai R
Br J Surg; 2015 Mar; 102(4):291-306. PubMed ID: 25689291
[TBL] [Abstract][Full Text] [Related]
18. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
19. Update in adrenocortical carcinoma.
Fassnacht M; Kroiss M; Allolio B
J Clin Endocrinol Metab; 2013 Dec; 98(12):4551-64. PubMed ID: 24081734
[TBL] [Abstract][Full Text] [Related]
20. Pediatric adrenocortical carcinoma.
Ilanchezhian M; Varghese DG; Glod JW; Reilly KM; Widemann BC; Pommier Y; Kaplan RN; Del Rivero J
Front Endocrinol (Lausanne); 2022; 13():961650. PubMed ID: 36387865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
